TACROLIMUS/SIROLIMUS/METHOTREXATE VERSUS TACROLIMUS/METHOTREXATE OR CYCLOSPORINE/MYCOPHENOLATE MOFETIL FOR GVHD PROPHYLAXIS AFTER REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA: